The authors have reviewed applications of novel technologies in the major stages of biosimilars development: process development, pharmacology, toxicology, and clinical trials, with an emphasis on recent regulatory requirements.
Zara Bukhari
Advertisement
Zara Bukhari is PhD scholar at the University of the Pacific, Stockton, CA. F
Articles by Zara Bukhari
Advertisement
Latest Updated Articles
Biosimilars Drug Development: Advances in Technologies from Molecule Design to Clinical TrialsPublished: August 7th 2024 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
2
Selecting the Right Drug Delivery Formulations to Enhance Patient-Centric Care
3
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
4
$1.8M RedHill Deal Highlights Growing Worldwide Focus on H. pylori Treatment Access
5
